Diagnostic and Interventional Cardiology

News | Congenital Heart

Smidt Heart Institute at Cedars-Sinai Welcomes Four New Specialists to Department of Cardiology

December 30, 2022 — The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of ...

December 30, 2022

News | Peripheral Artery Disease (PAD)

Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease ...

December 29, 2022

Protein could yield potential therapeutic strategy to detect and prevent cancer therapy-associated heart failure

News | Heart Failure

Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

December 29, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | Heart Valve Technology

Cedars-Sinai Designated as Mitral Valve Repair Reference Center

December 29, 2022 — The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a ...

December 29, 2022

Impella ECP, the world's smallest heart pump, is placed percutaneously into the heart's left ventricle. (Graphic: Business Wire)

News | Cardiovascular Clinical Studies

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

December 28 2022 — Abiomed announces the United States Food and Drug Administration (FDA) has approved the version of ...

December 28, 2022

Keyur Vora, MD, MS, George Revtyak, MD, and Rohan Dharmakumar, PhD with the first patient to enroll in a new cardiovascular clinical trial.

News | Cardiovascular Clinical Studies

First Patient Enrolls in IU-led Clinical Trial to Study Treatment for Acute Heart Attack Complications

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...

December 27, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | Cardiovascular Business

CAROL Act to Expand Research Funding, Raise Awareness for Valvular Heart Disease

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...

December 27, 2022

Two-day educational symposium was held in New York City at the NBPA’s headquarters

News | Cardiovascular Education

Morristown Medical Center’s Matthew Martinez, MD Held First Sports Cardiology Summit for Elite and Professional Athletes

December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...

December 26, 2022

Limited Exclusion Order would bar Apple from importing infringing Apple Watches

News | ECG

ITC Rules Apple Violated AliveCor’s Patents

December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

December 26, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

News | Diagnostic and Interventional Cardiology DAIC

Happy Holidays from DAIC

December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...

December 25, 2022

According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).

News | Stents Drug Eluting

Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

December 23, 2022

The first of its kind study involved 60 patients and confirmed Electroducer Sleeve as a safe and effective treatment for heart diseases

News | Guidewires

Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...

December 23, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.

News | Cardiovascular Business

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

December 22, 2022

Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si

News | Heart Failure

Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

December 22, 2022

The AcQCross Qx system combines the dilator and needle needed to perform left-atrial appendage closure procedures, eliminating the need to swap equipment mid-surgery while crossing into the left side of the heart. (Pixabay)

News | Left Atrial Appendage (LAA) Occluders

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

December 22, 2022